Response to Comment on Gregory et al. COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic's Impact in Type 1 and Type 2 Diabetes. Diabetes Care 2021;44:526-532

Response to Comment on Gregory et al. COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic's Impact in Type 1 and Type 2 Diabetes. Diabetes Care 2021;44:526-532

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes care 2021-05, Vol.44 (5), p.e103-e104
Hauptverfasser: Gregory, Justin M, Slaughter, James C, Duffus, Sara H, Smith, T Jordan, LeStourgeon, Lauren M, Jaser, Sarah S, McCoy, Allison B, Luther, James M, Giovannetti, Erin R, Boeder, Schafer, Pettus, Jeremy H, Moore, Daniel J
Format: Artikel
Sprache:eng
Schlagworte:
COVID-19
Diabetes Mellitus, Type 2 - epidemiology
e-Letters: Comments and Responses
Humans
Pandemics
Prospective Studies
SARS-CoV-2
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e104
container_issue 5
container_start_page e103
container_title Diabetes care
container_volume 44
creator Gregory, Justin M
Slaughter, James C
Duffus, Sara H
Smith, T Jordan
LeStourgeon, Lauren M
Jaser, Sarah S
McCoy, Allison B
Luther, James M
Giovannetti, Erin R
Boeder, Schafer
Pettus, Jeremy H
Moore, Daniel J
description
doi_str_mv 10.2337/dci21-0005
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8132332</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2525653972</sourcerecordid><originalsourceid>FETCH-LOGICAL-c308t-838c03447cae18cd893c14add4432473fc250caac2a909829c936a4e010886903</originalsourceid><addsrcrecordid>eNpVkV2LEzEUhoMobq3e-APk3CnC1Hy2yQpC6epaWNhFq7chmzndjcxMxiQt9C_6q5y2a1mvEnjfPCech5DXjE64ELMPtQ-cVZRS9YSMmBGqUkrqp2REmTSVMoafkRc5_xoaUmr9nJwJYWZccDYif75h7mOXEUqERWxb7ArEDi4T3sW0Ayzgmgksrn8uLypm4DtuMYWyg2WGVQp9gzWEDso9wkVwt1gwHzCbbiidwxxuUsw9-hK2CPPONbscMsT14cWN62psg3-bYdn2zpc9arXrERgM0fHKT-DJoxEuDQnl7KOU54pPKyX4S_Js7ZqMrx7OMfnx5fNq8bW6ur5cLuZXlRdUl0oL7amQcuYdMu1rbYRn0tW1lILLmVh7rqh3znNnqNHceCOmTiJlVOupoWJMPh25_ea2xdoPG0uusX0KrUs7G12w_ydduLd3cWs1E4MvPgDePQBS_L3BXGwbssemcR3GTbZccTVVB0Vj8v5Y9cMac8L1aQyjdi_fHuTbvfyh_Obxx07Vf7bFX6bbqEw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2525653972</pqid></control><display><type>article</type><title>Response to Comment on Gregory et al. COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic's Impact in Type 1 and Type 2 Diabetes. Diabetes Care 2021;44:526-532</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Gregory, Justin M ; Slaughter, James C ; Duffus, Sara H ; Smith, T Jordan ; LeStourgeon, Lauren M ; Jaser, Sarah S ; McCoy, Allison B ; Luther, James M ; Giovannetti, Erin R ; Boeder, Schafer ; Pettus, Jeremy H ; Moore, Daniel J</creator><creatorcontrib>Gregory, Justin M ; Slaughter, James C ; Duffus, Sara H ; Smith, T Jordan ; LeStourgeon, Lauren M ; Jaser, Sarah S ; McCoy, Allison B ; Luther, James M ; Giovannetti, Erin R ; Boeder, Schafer ; Pettus, Jeremy H ; Moore, Daniel J</creatorcontrib><identifier>ISSN: 0149-5992</identifier><identifier>EISSN: 1935-5548</identifier><identifier>DOI: 10.2337/dci21-0005</identifier><identifier>PMID: 33972321</identifier><language>eng</language><publisher>United States: American Diabetes Association</publisher><subject>COVID-19 ; Diabetes Mellitus, Type 2 - epidemiology ; e-Letters: Comments and Responses ; Humans ; Pandemics ; Prospective Studies ; SARS-CoV-2</subject><ispartof>Diabetes care, 2021-05, Vol.44 (5), p.e103-e104</ispartof><rights>2021 by the American Diabetes Association 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c308t-838c03447cae18cd893c14add4432473fc250caac2a909829c936a4e010886903</citedby><cites>FETCH-LOGICAL-c308t-838c03447cae18cd893c14add4432473fc250caac2a909829c936a4e010886903</cites><orcidid>0000-0003-2700-0062 ; 0000-0002-7958-7662</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33972321$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gregory, Justin M</creatorcontrib><creatorcontrib>Slaughter, James C</creatorcontrib><creatorcontrib>Duffus, Sara H</creatorcontrib><creatorcontrib>Smith, T Jordan</creatorcontrib><creatorcontrib>LeStourgeon, Lauren M</creatorcontrib><creatorcontrib>Jaser, Sarah S</creatorcontrib><creatorcontrib>McCoy, Allison B</creatorcontrib><creatorcontrib>Luther, James M</creatorcontrib><creatorcontrib>Giovannetti, Erin R</creatorcontrib><creatorcontrib>Boeder, Schafer</creatorcontrib><creatorcontrib>Pettus, Jeremy H</creatorcontrib><creatorcontrib>Moore, Daniel J</creatorcontrib><title>Response to Comment on Gregory et al. COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic's Impact in Type 1 and Type 2 Diabetes. Diabetes Care 2021;44:526-532</title><title>Diabetes care</title><addtitle>Diabetes Care</addtitle><subject>COVID-19</subject><subject>Diabetes Mellitus, Type 2 - epidemiology</subject><subject>e-Letters: Comments and Responses</subject><subject>Humans</subject><subject>Pandemics</subject><subject>Prospective Studies</subject><subject>SARS-CoV-2</subject><issn>0149-5992</issn><issn>1935-5548</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkV2LEzEUhoMobq3e-APk3CnC1Hy2yQpC6epaWNhFq7chmzndjcxMxiQt9C_6q5y2a1mvEnjfPCech5DXjE64ELMPtQ-cVZRS9YSMmBGqUkrqp2REmTSVMoafkRc5_xoaUmr9nJwJYWZccDYif75h7mOXEUqERWxb7ArEDi4T3sW0Ayzgmgksrn8uLypm4DtuMYWyg2WGVQp9gzWEDso9wkVwt1gwHzCbbiidwxxuUsw9-hK2CPPONbscMsT14cWN62psg3-bYdn2zpc9arXrERgM0fHKT-DJoxEuDQnl7KOU54pPKyX4S_Js7ZqMrx7OMfnx5fNq8bW6ur5cLuZXlRdUl0oL7amQcuYdMu1rbYRn0tW1lILLmVh7rqh3znNnqNHceCOmTiJlVOupoWJMPh25_ea2xdoPG0uusX0KrUs7G12w_ydduLd3cWs1E4MvPgDePQBS_L3BXGwbssemcR3GTbZccTVVB0Vj8v5Y9cMac8L1aQyjdi_fHuTbvfyh_Obxx07Vf7bFX6bbqEw</recordid><startdate>20210501</startdate><enddate>20210501</enddate><creator>Gregory, Justin M</creator><creator>Slaughter, James C</creator><creator>Duffus, Sara H</creator><creator>Smith, T Jordan</creator><creator>LeStourgeon, Lauren M</creator><creator>Jaser, Sarah S</creator><creator>McCoy, Allison B</creator><creator>Luther, James M</creator><creator>Giovannetti, Erin R</creator><creator>Boeder, Schafer</creator><creator>Pettus, Jeremy H</creator><creator>Moore, Daniel J</creator><general>American Diabetes Association</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-2700-0062</orcidid><orcidid>https://orcid.org/0000-0002-7958-7662</orcidid></search><sort><creationdate>20210501</creationdate><title>Response to Comment on Gregory et al. COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic's Impact in Type 1 and Type 2 Diabetes. Diabetes Care 2021;44:526-532</title><author>Gregory, Justin M ; Slaughter, James C ; Duffus, Sara H ; Smith, T Jordan ; LeStourgeon, Lauren M ; Jaser, Sarah S ; McCoy, Allison B ; Luther, James M ; Giovannetti, Erin R ; Boeder, Schafer ; Pettus, Jeremy H ; Moore, Daniel J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c308t-838c03447cae18cd893c14add4432473fc250caac2a909829c936a4e010886903</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>COVID-19</topic><topic>Diabetes Mellitus, Type 2 - epidemiology</topic><topic>e-Letters: Comments and Responses</topic><topic>Humans</topic><topic>Pandemics</topic><topic>Prospective Studies</topic><topic>SARS-CoV-2</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gregory, Justin M</creatorcontrib><creatorcontrib>Slaughter, James C</creatorcontrib><creatorcontrib>Duffus, Sara H</creatorcontrib><creatorcontrib>Smith, T Jordan</creatorcontrib><creatorcontrib>LeStourgeon, Lauren M</creatorcontrib><creatorcontrib>Jaser, Sarah S</creatorcontrib><creatorcontrib>McCoy, Allison B</creatorcontrib><creatorcontrib>Luther, James M</creatorcontrib><creatorcontrib>Giovannetti, Erin R</creatorcontrib><creatorcontrib>Boeder, Schafer</creatorcontrib><creatorcontrib>Pettus, Jeremy H</creatorcontrib><creatorcontrib>Moore, Daniel J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Diabetes care</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gregory, Justin M</au><au>Slaughter, James C</au><au>Duffus, Sara H</au><au>Smith, T Jordan</au><au>LeStourgeon, Lauren M</au><au>Jaser, Sarah S</au><au>McCoy, Allison B</au><au>Luther, James M</au><au>Giovannetti, Erin R</au><au>Boeder, Schafer</au><au>Pettus, Jeremy H</au><au>Moore, Daniel J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Response to Comment on Gregory et al. COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic's Impact in Type 1 and Type 2 Diabetes. Diabetes Care 2021;44:526-532</atitle><jtitle>Diabetes care</jtitle><addtitle>Diabetes Care</addtitle><date>2021-05-01</date><risdate>2021</risdate><volume>44</volume><issue>5</issue><spage>e103</spage><epage>e104</epage><pages>e103-e104</pages><issn>0149-5992</issn><eissn>1935-5548</eissn><cop>United States</cop><pub>American Diabetes Association</pub><pmid>33972321</pmid><doi>10.2337/dci21-0005</doi><orcidid>https://orcid.org/0000-0003-2700-0062</orcidid><orcidid>https://orcid.org/0000-0002-7958-7662</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0149-5992
ispartof Diabetes care, 2021-05, Vol.44 (5), p.e103-e104
issn 0149-5992
1935-5548
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8132332
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects COVID-19
Diabetes Mellitus, Type 2 - epidemiology
e-Letters: Comments and Responses
Humans
Pandemics
Prospective Studies
SARS-CoV-2
title Response to Comment on Gregory et al. COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic's Impact in Type 1 and Type 2 Diabetes. Diabetes Care 2021;44:526-532
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T06%3A07%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Response%20to%20Comment%20on%20Gregory%20et%20al.%20COVID-19%20Severity%20Is%20Tripled%20in%20the%20Diabetes%20Community:%20A%20Prospective%20Analysis%20of%20the%20Pandemic's%20Impact%20in%20Type%201%20and%20Type%202%20Diabetes.%20Diabetes%20Care%202021;44:526-532&rft.jtitle=Diabetes%20care&rft.au=Gregory,%20Justin%20M&rft.date=2021-05-01&rft.volume=44&rft.issue=5&rft.spage=e103&rft.epage=e104&rft.pages=e103-e104&rft.issn=0149-5992&rft.eissn=1935-5548&rft_id=info:doi/10.2337/dci21-0005&rft_dat=%3Cproquest_pubme%3E2525653972%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2525653972&rft_id=info:pmid/33972321&rfr_iscdi=true